PHAR (Pharming Group N.V.) Stock Market Reviews

crown

search

Read and share opinions on PHAR (Pharming Group N.V.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

PHAR

Pharming Group N.V.

clarify Biotechnology

bookmark Healthcare

public Netherlands

Sell Neutral Buy

Latest News

Earnings Estimates Moving Higher for Pharming Group (PHAR): Time to Buy?
Nov 10, 2025
Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect?
Nov 10, 2025
Pharming Group (ENXTAM:PHARM) Is Up 22.9% After Raising Revenue Guidance and FDA Progress – Has the Bull Case Changed?
Nov 8, 2025
Pharming Group (PHGUF) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Adjustments
Nov 6, 2025
Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
Oct 30, 2025
Pharming Group to report third quarter 2025 financial results and provide business update on November 6
Oct 23, 2025
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Oct 20, 2025
Pharming Group (ENXTAM:PHARM): Assessing Valuation Following Major Cost-Cutting and Restructuring Move
Oct 10, 2025
Pharming Group provides update on previously announced G&A expense reduction plan
Oct 6, 2025
Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years
Oct 1, 2025

Reviews